These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20391433)

  • 1. Blood-stage Plasmodium berghei infection leads to short-lived parasite-associated antigen presentation by dendritic cells.
    Lundie RJ; Young LJ; Davey GM; Villadangos JA; Carbone FR; Heath WR; Crabb BS
    Eur J Immunol; 2010 Jun; 40(6):1674-81. PubMed ID: 20391433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL; Snyder HL; Krzych U
    J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity.
    Wilson NS; Behrens GM; Lundie RJ; Smith CM; Waithman J; Young L; Forehan SP; Mount A; Steptoe RJ; Shortman KD; de Koning-Ward TF; Belz GT; Carbone FR; Crabb BS; Heath WR; Villadangos JA
    Nat Immunol; 2006 Feb; 7(2):165-72. PubMed ID: 16415871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation in immunity to murine malaria.
    Lundie RJ
    Curr Opin Immunol; 2011 Feb; 23(1):119-23. PubMed ID: 20951016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Novel CD4
    Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
    J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium berghei XAT: contribution of gammadelta T cells to host defense against infection with blood-stage nonlethal malaria parasite.
    Kobayashi F; Niikura M; Waki S; Matsui T; Fujino T; Tsuruhara T; Kamiya S
    Exp Parasitol; 2007 Dec; 117(4):368-75. PubMed ID: 17601562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction and expression of Plasmodium berghei chimeric protein in Pichia pastoris and its immunogenicity in mice].
    Cao Y; Zhang DM; Pan WQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct; 26(5):327-31. PubMed ID: 19157293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune status of Kupffer cells profoundly influences their responses to infectious Plasmodium berghei sporozoites.
    Steers N; Schwenk R; Bacon DJ; Berenzon D; Williams J; Krzych U
    Eur J Immunol; 2005 Aug; 35(8):2335-46. PubMed ID: 15997465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
    Hetttihewa LM
    Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of major histocompatibility complex (MHC) antigen in nephritis associated with murine malaria infection.
    Rui-Mei L; Kara AU; Sinniah R
    J Pathol; 1998 Jun; 185(2):212-8. PubMed ID: 9713350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
    Tartz S; Kamanova J; Simsova M; Sebo P; Bolte S; Heussler V; Fleischer B; Jacobs T
    Infect Immun; 2006 Apr; 74(4):2277-85. PubMed ID: 16552058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
    González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
    Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection.
    Langhorne J; Albano FR; Hensmann M; Sanni L; Cadman E; Voisine C; Sponaas AM
    Immunol Rev; 2004 Oct; 201():35-47. PubMed ID: 15361231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation of CXCL12 (CXCL12) induces homing of CD11c+ dendritic cells to the spleen and enhances control of Plasmodium berghei malaria in BALB/c mice.
    Garnica MR; de Moraes LV; Rizzo LV; de Andrade HF
    Immunology; 2005 Jul; 115(3):399-406. PubMed ID: 15946257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On cross-priming of MHC class I-specific CTL: rule or exception?
    Zinkernagel RM
    Eur J Immunol; 2002 Sep; 32(9):2385-92. PubMed ID: 12207322
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigen presentation by dendritic cells in vivo.
    Segura E; Villadangos JA
    Curr Opin Immunol; 2009 Feb; 21(1):105-10. PubMed ID: 19342210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium berghei XAT: protective 155/160 kDa antigens are located in parasitophorous vacuoles of schizont-stage parasite.
    Kobayashi F; Waki S; Niikura M; Tachibana M; Tsuboi T; Torii M; Kamiya S
    Exp Parasitol; 2007 Aug; 116(4):450-7. PubMed ID: 17442306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses.
    Hansen DS; Siomos MA; De Koning-Ward T; Buckingham L; Crabb BS; Schofield L
    Eur J Immunol; 2003 Sep; 33(9):2588-98. PubMed ID: 12938235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.